β Home
Stryker Corp
-14.9%
Healthcare & biotech / Orthopedics, medical and surgical, and neurotechnology and spine applications
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (465) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ€ Insider Trades
| Date | Type | Name | A/D | Amount | Price | Security |
|---|---|---|---|---|---|---|
| 2025-04-01 | Montagnino Kimberly Ann officer: VP, Chief Comm. Officer |
1376 | 392.39 | Employee Stock Option granted 02/05/2025 (right to buy) | ||
| 2025-04-01 | Wells Preston Wendell officer: VP, Chief Financial Officer |
9176 | 392.39 | Employee Stock Option granted 02/05/2025 (right to buy) | ||
| 2025-03-21 | M-Exempt | Stiles Spencer S officer: Group President |
D | 314 | Dividend Equivalents | |
| 2025-03-21 | M-Exempt | Pierce James Andrew officer: Group President |
D | 314 | Dividend Equivalents | |
| 2025-03-21 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-21 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-21 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-21 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-21 | ***** | ***** |
***** | ***** | ***** | ***** |
ποΈ Explore more insider trade data for Stryker Corp!
Sign up for free or log inπ Join now to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" at no cost